Latest Insider Transactions at Turnstone Biologics Corp. (TSBX)
This section provides a real-time view of insider transactions for Turnstone Biologics Corp. (TSBX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Turnstone Biologics Corp. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Turnstone Biologics Corp.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 25
2023
|
Davis Jerel |
BUY
Open market or private purchase
|
Indirect |
225,000
+6.75%
|
$2,700,000
$12.0 P/Share
|
|
Jul 25
2023
|
Davis Jerel |
BUY
Conversion of derivative security
|
Indirect |
3,156,692
+50.0%
|
-
|
|
Jul 25
2023
|
Versant Ventures V, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
225,000
+6.75%
|
$2,700,000
$12.0 P/Share
|
|
Jul 25
2023
|
Versant Ventures V, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
3,156,692
+50.0%
|
-
|
|
Jul 25
2023
|
Fmr LLC |
BUY
Conversion of derivative security
|
Indirect |
1,133,987
+41.98%
|
-
|
|
Jul 20
2023
|
Rishi Gupta |
BUY
Open market or private purchase
|
Indirect |
416,666
+11.85%
|
$4,999,992
$12.0 P/Share
|
|
Jul 20
2023
|
Rishi Gupta |
BUY
Conversion of derivative security
|
Indirect |
2,682,599
+50.0%
|
-
|
|
Jul 20
2023
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
416,666
+11.85%
|
$4,999,992
$12.0 P/Share
|
|
Jul 20
2023
|
Orbimed Advisors LLC Director |
BUY
Conversion of derivative security
|
Indirect |
2,682,599
+50.0%
|
-
|